FDA approves new drug for carcinoid syndrome diarrhoea

01 Mar 2017


The FDA has approved a new drug to treat cases of carcinoid syndrome diarrhoea, which do not respond to somatostatin analogues alone.

Medpage Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story